Jonathan Jay Mazelsky Idexx Laboratories Inc (IDXX) insider trading activity

Jonathan Jay Mazelsky is President and CEO of IDEXX LABORATORIES INC . Currently has a direct ownership of 82,443 shares of IDXX, which is worth approximately $59.6 Million. The most recent transaction as insider was on Nov 14, 2022, when has been sold 18,998 shares (Common Stock) at a price of $62.0 per share, resulting in proceeds of $1,177,876. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 82.4K

1.01% 3M change

0.87% 12M change

Total Value Held $59.6 Million

JONATHAN JAY MAZELSKY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 14 2022	BUY Exercise of conversion of derivative security	$1,177,876 $62.0 p/Share	18,998 Added 18.94%	81,304 Common Stock
Nov 07 2022	SELL Open market or private sale	$5,054,918 $382.08 p/Share	13,230 Reduced 17.51%	62,306 Common Stock
Nov 07 2022	BUY Exercise of conversion of derivative security	$1,248,104 $52.0 p/Share	24,002 Added 24.11%	75,536 Common Stock
Aug 05 2022	SELL Payment of exercise price or tax liability	$72,993 $407.78 p/Share	179 Reduced 0.35%	51,517 Common Stock
Aug 05 2022	BUY Exercise of conversion of derivative security	-	385 Added 0.74%	51,696 Common Stock
May 20 2022	BUY Exercise of conversion of derivative security	$99,970 $141.6 p/Share	706 Added 1.36%	51,300 Common Stock
Mar 04 2022	SELL Bona fide gift	-	500 Reduced 0.98%	50,585 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$719,369 $505.53 p/Share	1,423 Reduced 2.71%	51,085 Common Stock
Feb 14 2022	BUY Exercise of conversion of derivative security	-	3,063 Added 5.51%	52,508 Common Stock
Aug 16 2021	SELL Open market or private sale	$851,249 $673.99 p/Share	1,263 Reduced 2.49%	49,426 Common Stock
Aug 13 2021	SELL Open market or private sale	$3,204,249 $676.43 p/Share	4,737 Reduced 8.55%	50,689 Common Stock
Aug 05 2021	SELL Payment of exercise price or tax liability	$126,331 $705.76 p/Share	179 Reduced 0.32%	55,426 Common Stock
Aug 05 2021	BUY Exercise of conversion of derivative security	-	385 Added 0.69%	55,605 Common Stock
May 18 2021	SELL Bona fide gift	-	500 Reduced 0.9%	55,209 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	$100,079 $67.85 p/Share	1,475 Added 2.58%	55,697 Common Stock
Feb 17 2021	SELL Open market or private sale	$7,479,705 $539.35 p/Share	13,868 Reduced 20.37%	54,222 Common Stock
Feb 17 2021	BUY Exercise of conversion of derivative security	$1,300,000 $52.0 p/Share	25,000 Added 26.86%	68,090 Common Stock
Feb 14 2021	SELL Payment of exercise price or tax liability	$787,284 $544.08 p/Share	1,447 Reduced 3.25%	43,090 Common Stock
Feb 14 2021	BUY Exercise of conversion of derivative security	-	3,110 Added 6.53%	44,537 Common Stock
Nov 06 2020	BUY Exercise of conversion of derivative security	$202,968 $70.77 p/Share	2,868 Added 6.48%	41,413 Common Stock
Nov 05 2020	SELL Bona fide gift	-	600 Reduced 1.53%	38,545 Common Stock
Nov 05 2020	SELL Open market or private sale	$2,449,579 $470.53 p/Share	5,206 Reduced 11.74%	39,145 Common Stock

Also insider at

XRAY

DENTSPLY SIRONA Inc. Healthcare

Director

JJM